UK variant could be behind current Covid-19 surge in Delhi: NCDC chief

Its prevalence in genomes sequenced nearly doubled from the second to the last week of March: NCDC chief

covid testing
A health worker collects a nasal sample from a passenger for COVID-19 test, amid coronavirus pandemic, in New Delhi,
Press Trust of India New Delhi
2 min read Last Updated : Apr 23 2021 | 7:37 PM IST

The current wave of the coronavirus pandemic in Delhi could have been fuelled by the UK variant as its prevalence in genomes sequenced nearly doubled from the second to the last week of March, Sujeet Singh, director of the National Centre for Disease Control, said on Friday.

Speaking at a webinar, 'Genome Sequencing of SARS-CoV-19', Singh said the UK variant of coronavirus is also dominant in Punjab.

In Delhi, there are primarily two types of variants -- B.1.617 and the UK strain -- found in the genome sequenced samples, the NCDC director said.

The B.1.617 variant of coronavirus is also known as the double mutant strain.

The UK variant was found in 28 per cent of samples in the second week of March. In the last week of the month, 50 per cent of samples had this variant, Singh said.

"If we try to co-relate, the surge we are observing in Delhi, it directly co-relates to the type of variant which we are observing," he said.

So far, Singh said, 15,133 samples have been sequenced by INSACOG, a consortium formed in December last year to increase viral genomic surveillance in order to understand the spread of the coronavirus in a rapid and robust manner.

This was also after the UK, South African and Brazilian strains, which have a higher rate of transmission, emerged.

Singh said in Maharashtra, the B.1.617 variant was found in proportions of over 50 per cent in many cities.

The NCDC is one of the 10 laboratories involved in the genome sequencing of coronavirus.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

First Published: Apr 23 2021 | 7:29 PM IST

Next Story